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Background: Malaria still causes high morbidity and mortality around the world, mainly in sub-Saharan Africa.
Community case management of malaria (CCMm) by community health workers (CHWs) is one of the strategies to
combat the disease by increasing access to malaria treatment. Currently, the World Health Organization
recommends to treat only confirmed malaria cases, rather than to give presumptive treatment.
Objectives: This systematic review aims to provide a comprehensive overview of the success or failure of critical
steps in CCMm with rapid diagnostic tests (RDTs).
Methods: The databases of Medline, Embase, the Cochrane Library, the library of the ‘Malaria in Pregnancy’
consortium, and Web of Science were used to find studies on CCMm with RDTs in SSA. Studies were selected
according to inclusion and exclusion criteria, subsequently risk of bias was assessed and data extracted.
Results: 27 articles were included. CHWs were able to correctly perform RDTs, although specificity levels were
variable. CHWs showed high adherence to test results, but in some studies a substantial group of RDT negatives
received treatment. High risk of bias was found for morbidity and mortality studies, therefore, effects on morbidity
and mortality could not be estimated. Uptake and acceptance by the community was high, however negative-tested
patients did not always follow up referral advice. Drug or RDT stock-outs and limited information on CHW motivation
are bottlenecks for sustainable implementation. RDT-based CCMm was found to be cost effective for the correct
treatment of malaria in areas with low to medium malaria prevalence, but study designs were not optimal.
Discussion: Trained CHWs can deliver high quality care for malaria using RDTs. However, lower RDT specificity could
lead to missed diagnoses of non-malarial causes of fever. Other threats for CCMm are non-adherence to negative test
results and low referral completion. Integrated CCM may solve some of these issues. Unfortunately, morbidity and
mortality are not adequately investigated. More information is needed about influencing sociocultural aspects, CHW
motivation and stock supply.
Conclusion: CCMm is generally well executed by CHWs, but there are several barriers for its success. Integrated CCM
may overcome some of these barriers.
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Malaria affects over 300 million people every year, with
around 90% of infections occurring in sub-Saharan Africa
(SSA) [1,2]. Community case management of malaria
(CCMm), formerly known as home based management of
malaria, is a strategy recommended by the World Health
Organization (WHO) which aims at reducing the malaria
burden by improving early access to malaria directed
healthcare [3]. It is based on treatment of malaria cases,
mainly children, by community health workers (CHWs),
within the community. Different cadres exist for CHWs,
but all these individuals have in common that they are
part of the community, they are not professional
healthcare workers but receive a short training and
often work on a voluntary basis or for small compensation
(although in some countries they are included in the
salaried healthcare system). While fever cases were
previously treated presumptively with anti-malarials,
CCMm programmes are now expected to follow the
WHO recommendation to treat only malaria patients with
confirmed diagnosis, usually with rapid diagnostic tests
(RDTs) [4]. It is expected that this will reduce unnecessary
malaria treatment and increase correct diagnosis in patients
suffering from other febrile illnesses. Three published
reviews describe RDT use in CCMm, however, the issues
discussed in these reviews are limited [5,6] and not all of
the important literature was included [6], or CHWs were
not distinguished from professional healthcare providers
[7]. Systematically obtained information on the success or
failure of critical steps in RDT-based CCMm is lacking,
but is needed in order to show its value in malaria control
programmes. Furthermore, the WHO currently advises
to proceed to integrated community case management
(iCCM) [8], which focuses on the diagnosis and treatment
of multiple diseases such as malaria, pneumonia and diar-
rhoea, and lessons from CCMm should be used during
this transition. This systematic review aims to provide a
comprehensive overview of the success or failure of critical
steps in CCMm with rapid diagnostic tests (RDTs).
Methods
Search methodology
A systematic search was performed in the databases of
Medline, Embase, the Cochrane Library and the library of
the ‘Malaria in Pregnancy’ consortium (MIP consortium).
Web of Science was used to search for missed relevant
studies in references and citing articles. The databases were
last searched on October 12, 2013. Synonyms for ‘malaria’,
‘RDT’ and ‘CHW’ were combined to find all relevant stud-
ies. For the complete search syntax see Additional file 1.
Selection of studies
After removal of duplicates, title and abstract of arti-
cles were screened for in- and exclusion criteria by twoindependent readers (ER and PFM). A second screen-
ing was performed on full text articles. Discrepant re-
sults were resolved by discussion until a unanimous
decision was reached. Criteria for inclusion were: ori-
ginal studies on RDT-based CCMm performed by
CHWs defined as non-professional healthcare workers
working within a community, studies on Plasmodium
falciparum malaria, studies on one of the following
critical steps: test performance by CHWs, execution of
test, test interpretation, adherence to test results by
CHWs, effect on morbidity and mortality, adherence to
test results by patients, referral completion, social accept-
ance, community uptake, stock-outs, CHW incentives and
motivation and cost-effectiveness. Exclusion criteria
were: studies on iCMM in which the individual effect of
RDT-based CCMm on the outcome cannot be identified
and studies outside SSA. The focus on SSA was chosen
because of the specific malaria epidemiology with a high
burden of P. falciparum malaria and high morbidity and
mortality rates [9]. Authors of relevant conference abstracts
were contacted for more detailed results and information
on methodology; in case of no additional information, no
response, or if full study details did not meet in- or exclu-
sion criteria, these abstracts were excluded.
Data extraction
Data were extracted from included studies by two in-
dependent readers (ER and PFM) and additionally for
social-behavioural themes by SD and KPG. Critical ap-
praisal was done in Review Manager [10] for intervention
and diagnostic studies. Evers checklist was used for studies
on cost-effectiveness according to Cochrane advice [11].
For all other studies, criteria are not well defined in lit-
erature, so criteria were defined per outcome. No studies
were discarded based on qualitative assessment. If pos-
sible, separate data for CCMm from studies on integrated
CCM (iCCM) were extracted.
Analysis
A forest plot was created of the RDT test characteristics
by the use of Review Manager. No meta-analysis was per-
formed due to heterogeneity of study characteristics and
outcomes. The same heterogeneity accounts for adher-
ence to test results. For the analysis of social-behavioural
themes, NVivo Software for qualitative data analysis
(QSR International Pty Ltd Cardigan, UK) was used.
Results
Search results
In total, 295 articles were found, of which 293 were by
database searching and two via other sources. The latter
articles were found after e-mail contact with authors of two
abstracts [12,13]. Both referred to an article that could not
be found in any of the databases [14,15]. After removal of
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exclusion criteria 27 articles remained for data extraction
(Figure 1). Exact reasons for exclusion of full text articles
can be found in Additional file 2. One article [16] provided
the same outcome information as another [17] (based on
the same study) and is, therefore, not separately discussed.
In Additional file 3, an overview of the included studies
is presented and for each of the critical steps the number
of articles and relevant articles are indicated. Most of the
articles were published between 2008 and 2013.
Risk of bias summary
Risk of bias was assessed for each study for every outcome
(Figures 2, 3, 4, 5, 6, 7, 8 and 9). Nearly all studies on RDT
performance showed low risks of bias. The same accounted
for RDT execution, although Counihan et al. [18] some-
times used non-febrile volunteers instead of patients for
RDT observations and Harvey et al. [19] showed baseline
differences in the groups of CHWs. Adherence to test
results showed little bias, although it was often unclear
how studies collected data. One study on adherence
showed a possible patient selection bias because a largeFigure 1 Flow chart of search strategy.group of malaria-suspected patients was not tested at all
[20]. More variable quality was found in studies on
interpretation, healthcare-seeking behaviour, stock-outs
and cost-effectiveness. In all three cost-effectiveness studies,
debatable assumptions were made: sensitivity and specifi-
city used for calculations were derived from studies on
professional healthcare workers instead of CHWs [21-23].
Furthermore, in two cost-effectiveness analyses adherence
to test results was assumed to be 100% [21,22]. High risk of
bias was seen for all studies concerning morbidity and
mortality; none met the preferred intervention design of
a double-blind, randomized, controlled trial (RCT). At
the same time, blinding patients and CHWs is impossible
for this type of intervention. It is therefore unfortunate that
the one study that described a non-blinded cluster RCT
used a subjective outcome measure (patients’ reporting
of clinical recovery), potentially introducing bias [24].
The other studies were either not randomized [25], or
were single-armed, pre- and post-intervention studies
[26,27]. It should be noted that studies that showed high
risk of bias for a certain outcome did not necessarily
show high risk of bias for their main objective.
Figure 2 Risk of bias summary for test performance. + = low
risk of bias, ? = unclear, - = high risk of bias.
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Sensitivity and specificity of RDTs when performed by
CHWs was assessed in seven studies (Figure 10 and Table 1).
Studies differed in participants, malaria transmission and
RDT type used. Sensitivities ranged between 83.2 and
97.9% if RDTs were compared with microscopy as reference
standard. Ishengoma et al. found that the sensitivity was
significantly higher for cases < five years of age and for fever
cases [28]. Sensitivity decreased with decreasing malaria
transmission over the years in this study [28], but this was
not confirmed in Tiono et al. [14]. Ratsimbasoa et al. add-
itionally calculated RDT sensitivity with PCR as reference
standard (RS) and found a sensitivity of 61.8% [29].
The specificity of RDTs in the hands of CHWs was
found to be more variable than the sensitivity, ranging
from 39% in the study of Chinkhumba et al. [30] to
95.1% in the study of Lemma et al. [22]. In ChinkhumbaFigure 3 Risk of bias summary for direct interpretation of RDT. + = loet al. [30] patients who self-treated with anti-malarials
(2-8% in previous two weeks) were not excluded and
this was associated with a lower specificity. Mubi et al.
[24] also showed low specificity, but it was mentioned that
the microscopy slides were of poor quality, possibly impair-
ing the detection of parasites in actual true positive sam-
ples. Slide quality was not mentioned in Tiono et al. [14],
who found a low specificity, especially in the high transmis-
sion season (25.4%). The conditions for RDT storage were
appropriate and the authors mainly related the results to
persistent circulating antigens [14]. In Ishengoma et al. a
higher specificity for children < five years of age was shown
compared with older patients [28].
RDT interpretation
RDT interpretation was assessed by either direct assess-
ment of RDTs (five studies) or by photographic assessment
(two studies) (see Table 2). Correct interpretation was high
for the direct assessment of RDTs; 96 to 100% of tests and
95.1 to 100% of CHWs, provided that CHWs were trained
properly [18,19,21,32]. In photographic assessments, which
have the inherent risk of selection bias as the number of
ambiguous tests is relatively high, well-trained CHWs
also scored high numbers of correctly interpreted tests,
although more mistakes were made in reading faint posi-
tive and invalid tests [18,19]. The importance of training
was shown for direct interpretation of RDTs as well as for
photographic assessment in Harvey et al. [19]. In both
assessments correct interpretation was lowest for CHWs
who used only manufacturer’s instructions, better for
CHWs who used a job aid and the best for CHWs who
used a job aid and received three hours’ training. Unfortu-
nately, a risk of selection bias was present because CHWs
were not randomly selected and completion of secondary
education was 6, 19 and 35%, respectively. Some indica-
tions were also found for the beneficial effect of repetitive
execution of RDTs. In Harvey et al. improvement was seen
with each successive RDT, although these data were notw risk of bias, ? = unclear, - = high risk of bias.
Figure 4 Risk of bias summary for interpretation of photographs. + = low risk of bias, ? = unclear, - = high risk of bias.
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by Counihan et al. [18]; the percentage of CHWs correctly
interpreting RDT results from patients or volunteers at
three, six and 12 months after training was 95.1, 98.3
and 98.3%, respectively. In contrast, this was not the case
with the ten-item photographic assessment in which four
CHWs consistently showed poor interpretation.
Execution of RDTs
Execution of RDTs was investigated in five studies that
used non-uniform outcome variables (see Table 2). The
way CHWs executed RDTs was judged on several items,
but differences in number and definition of items further
impaired comparison [18-21,32]. Nevertheless CHWs were
found to correctly conduct RDTs if properly trained; 90 to
100% of steps were successfully executed in two studies that
used the same WHO checklist, Hawkes et al. [21] and
Harvey et al. [19]. In contrast, untrained CHWs that
used only manufacturer’s instructions or a job aid were
found to respectively conduct only 57 and 80% of steps
correctly in Harvey et al. [19]. The assessment of each
individual executed step in this study showed that problems
were found in dispensing buffer drops, waiting correct
amount of time, pricking side of finger, blood collec-
tion and recording result in register. Counihan et al.
[18], who assessed only the execution of eight RDT stepsFigure 5 Risk of bias summary for RDT execution. + = low risk of bias,(see Additional file 4) that were considered critical for
diagnosis or safety, showed improvement over time:
40.3, 61.7 and 79.7% of CHWs correctly performed critical
steps at three, six and 12 months, respectively. Problematic
steps were writing patient’s name on cassette, recording re-
sults in register, usage of the blood collection loop, reading
the test result in the right time and disposing non-sharps in
non-sharps container [18-20]. Why these steps were prob-
lematic was not studied. No specific studies were done that
looked at safety issues while performing RDTs but some in-
cluded particular findings. Ndiaye et al. [20] observed that
0% of CHWs used gloves, but this was partly due to stock
problems. In contrast, high levels of glove use were reported
in Counihan et al. [18] (100% of CHWs after 12 months)
and Harvey et al. [19] (96% in the group of trained CHWs).
In Counihan et al. [18] an observer had to intervene
once because a CHW was about to re-use a lancet on a
new patient.
Adherence to test results and referral guidelines by CHWs
In general almost all patients (>90.0%) with positive
RDTs were provided with anti-malarial drugs by CHWs
(Table 3). The percentage of patients with negative RDTs
who, contradictory to the guidelines, still received anti-
malarial treatment was more variable, ranging from 0.2
to 58%. Six studies showed levels <10%, including all? = unclear, - = high risk of bias.
Figure 6 Risk of bias summary for adherence. + = low risk of bias, ? = unclear, - = high risk of bias.
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[20] and 58% [30] of negative-tested patients that were
treated. One other study presented the percentage of
CHWs adhering to test results and showed that 30% of
them treated negative-tested patients based on clinical
judgment rather than RDT result; this was not related
to previous experience in malaria management or edu-
cational background [27]. Ndiaye et al. [20] showedFigure 7 Risk of bias summary for intervention studies on morbidity
and mortality. + = low risk of bias, ? = unclear, - = high risk of bias.that the adherence was related to the type of care pro-
viders in their study. Community medicine distributors
(CMDs) were only trained on RDT-based malaria man-
agement, while CHWs were attributed more health
intervention tasks. CHWs gave artemisinin-combination
therapy (ACT) to 24.8% of RDT negatives, while CMDs
gave ACT to 10.4% of RDT negatives. Besides treating
a high number of negative patients, CHWs also treated
22.3% of patients with ACT who were not tested at all,
while for CMDs this was only 0.8%. Furthermore, CHWs
and CMDs did not comply with the referral policy; referral
rates from patient groups that should have been referred
ranged from 18.2 to 47.1% with the lowest referral rates
found for babies < two months of age and patients with se-
vere symptoms. The only other study reporting on referral
by CHWs showed better results, in the first year, 79.5% of
RDT negatives were referred according to protocol and in
the second year this had increased to 97.4% [25]. No ex-
planations were given in the studies on reasons for non-
adherence regarding treatment of negatives and referral.
Morbidity and mortality
Four trials assessed outcomes related to morbidity, mor-
tality or both (Table 4), but all showed low quality evi-
dence (Figure 7) impairing firm conclusions. One study
reported lower slide positivity rates during the RDT-based
CCMm intervention period in comparison with presump-
tive CCMm in the pre-intervention period. However, be-
sides changing to RDT-based diagnosis, the type of anti-
malarial drug used changed from sulphadoxine-
pyrimethamine to an ACT in this study [26]. Two other
Figure 8 Risk of bias summary for cost-effectiveness studies. +
= low risk of bias, ? = unclear, - = high risk of bias.
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but only compared it to areas with no CCMm [25,27]. In
contrast, the perception of patients on morbidity did not
improve with RDT-based CMMm. In a randomized,
cross-over trial on RDT-based CCMm versus presumptive
CCMm, a significant increased perception of disease
recovery was found in the presumptively treated patients
at day 7 compared with the intervention arm (97.3 versus
93.3%, p = 0.000). More patients were treated with anti-
malarials in the control group; however, in both the inter-
vention and control group the perceived unrecovered
patients harboured only few malaria positives (repeated
testing at day 7), thus suggesting a possible bias in the
subjective study outcome [24].Community acceptance
Studies by Mukanga et al. [35] in Uganda and Nsagha
et al. [36] in Cameroon assessed the opinion of community
members before introducing an RDT-based CCMm inter-
vention. In Mukanga et al. [35] presumptive CCMm was
already implemented and a positive attitude towards the
CHWs was present, due to their voluntary services, accessi-
bility and the effectiveness of provided drugs. The changeFigure 9 Risk of bias summary for healthcare-seeking behaviour. + =to CHWs using RDTs was therefore well received. In
Nsagha et al. [36] all participants would welcome RDTs,
but in this urban setting, where other healthcare providers
are available, CHWs were not always considered to be
the appropriate persons to carry out RDTs. Participants
in both studies stressed that proper training of CHWs
on RDT use was considered essential.
A few years later Mukanga et al. [37] asked community
members in Uganda for their opinion after introduc-
tion of RDT-based CCMm; 79.4% thought CHWs’ ser-
vice was better after introduction of RDTs and 88.7%
thought CHWs should continue to use RDTs. Support
for a high acceptance was also found in Senegal, where
community members mainly praised the increased ac-
cess to malaria care [38]. Furthermore, in several stud-
ies participants welcomed RDTs since it made correct
diagnosis possible at the village level, which saved money
on transport [27,36,38].
Acceptability of diagnosis and treatment by CHWs was
related to the outcome of the RDT. Only 5% of CHWs
had problems persuading RDT-positive patients of a
malaria diagnosis in Sudan [27]. This is supported by
Mubi et al. [24], in which 97.4% of patients complied
to prescribed treatment after a positive RDT. However,
persuading patients that they did not have malaria was
problematic for 20% of CHWs in case of negative test
results [27], an issue that was already predicted by
Mukanga et al. [35].
Adherence to referral advice by patients was reported
in only two studies [33,39]. Chanda et al. [33] used a system
in which CHWs were notified by health centre staff if a re-
ferred patient visited the health centre. For 40 to 42% of the
referrals feedback was received. In contrast, Thomson et al.
[39] found a very low referral completion of 1.5%. They sur-
veyed children three to 59 months and pregnant women in
their second and third trimester in Sierra Leone. A large
variation in referral completion was found within the differ-
ent communities (0 to 18.8%). Furthermore, if stratified
for RDT results, referral completion was 88.2% for RDT
positives (usually referred for signs of severe malaria) in
contrast to 0.9% for RDT negatives. Barriers for adherencelow risk of bias, ? = unclear, - = high risk of bias.
Figure 10 Forest plot of RDT performance when performed by CHWs (no subgroup analyses). Lemma 2011a = Paracheck Pf, Lemma
2011b = Parascreen pan/p.
Table 1 RDT test performance by CHWs
Study Target population RDT type Reference
standard (RS)
RS positive* (%) Sensitivity (%) Specificity (%)
Ratsimbasoa [29] >2 months (history of) fever CareStart PCR 56.7% 61.8% 95%
Ratsimbasoa [29] >2 months (history of) fever CareStart Microscopy of
thin and thick BS
37.2% 95.9% 87%
Chinkhumba [30] >5 years (history of) fever Bioline SD, First Response
malaria, Paracheck PF
Microscopy of
thick BS (expert)
38.5% 95% 43%
Chinkhumba [30]** >5 years (history of) fever Bioline SD Microscopy of
thick BS (expert).
41% 97% 39%
Chinkhumba [30]** >5 years (history of) fever First response malaria Microscopy of
thick BS (expert).
40% 92% 42%
Ishengoma [28] All ages, care seeking Paracheck Pf, ParaHIT Microscopy of
thick and thin BS.
20.8% 88.6% 88.2%
Ishengoma [28] < 5 years Paracheck Pf, ParaHIT Microscopy of
thick and thin BS
19.7% 90.1% 93.6%
Ishengoma [28] ≥5 years Paracheck Pf, ParaHIT Microscopy of
thick and thin BS
21% 88.3% 86.5%
Ishengoma [28] No fever patients Paracheck Pf, ParaHIT Microscopy of
thick and thin BS
14.5% 84.7% 90.1%
Ishengoma [28] Fever patients Paracheck Pf, ParaHIT Microscopy of
thick and thin BS
33.9% 92.2% 82.9%
Lemma [22]** >3 months suspected of malaria Paracheck Pf Microscopy of
thick BS.
18.7% 88.7% 94.2%
Lemma [22]** >3 months suspected of malaria Parascreen Microscopy of
thick BS.
18.7% 83.2% 95.1%
Mubi [24] >3 months (history of) fever. Paracheck Pf Microscopy of
thick BS.
22.6% 85.3% 59.8%
Premji [31] Children <42 months Parasight TM-F test Microscopy of
thin and thick BS.
66.6% 84% 81%
Tiono [14] Children 6–59 months
with (history of) fever.
FirstSign Malaria Pf Microscopy of
thin and thick BS.
54.8% 97.9% 53.4%
Tiono [14] Children 6–59 months
with (history of) fever.
(High transmission)
FirstSign Malaria Pf Microscopy of
thin and thick BS.
76.1% 98% 25.4%
Tiono [14] Children 6–59 months
with (history of) fever.
(Low transmission)
FirstSign Malaria Pf Microscopy of
thin and thick BS.
31.8% 97.6% 63.7%
*P. falciparum, **Two types of RDTs separately tested.
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Table 2 Interpretation and execution of RDTs by CHWs
Study CHW training Outcome interpretation Outcome execution
Counihan [18] Half-day training. At 3 months CHWs
received a poster-sized job aid and a
photographic guide on RDT
interpretation.
(I) RDT test results correctly read by 95.1,
98.3 and 98.3% of the CHWs at 3, 6 and
12 months after training respectively.
19-item checklist, interpretation included,
8 items were considered critical.
(II) Correct interpretation of positive RDT
results was 96.5% at 3 months, 98.3% at
6 months and 90.5% at 12 months.
Median correctly performed critical steps
were 87.5%, 100% and 100% at 3, 6 and
12 months respectively.
(II) Correct interpretation of negative RDT
results was 94.3% at 3 months, 97.9% at
6 months and 94.7% at 12 months.
40.3, 61.7 and 79.7% of CHWs correctly
performed critical RDT steps at 3, 6 and
12 months respectively.
(II) Faint positive lines were correctly
interpreted by 89.7% at 3 months, 96.7%
at 6 months and declined to 76.7% at
12 months.
Mukanga [32] 8-day training by experienced trainers.
Job aid provided.
100% of the RDTs were correctly interpreted
shortly after training (<2 weeks).
96.3% of RDTs were correctly performed
shortly after training (<2 weeks) in a
14-item checklist, interpretation excluded.
Harvey [19] Group 1: only use of manufacturers’
instructions. Group 2: only use of
job aid. Group 3: 3- hour training on
RDTs + job aid.
(I) 72, 86 and 96% of CHWs correctly
interpreted RDT results for group 1, 2
and 3 respectively.
57% of steps, 80% of steps and 90% of
steps were correctly performed by group
1, 2 and 3 respectively at the same day of
receiving instructions, job aid or training in
a 16-item checklist, interpretation included.(II) 54, 82 and 93% of tests were correctly
interpreted for group 1, 2 and 3 respectively.
Hawkes [21] One day training. Pictorial job aid
was provided.
100% of CHWs correctly interpreted the
RDT directly after training.
Median score on a WHO 16-item
assessment of RDT performance was 100%
(range of 94-100%) directly after training.
Ndiaye [20] CHWs: one month theoretical training,
one month practical training at health
post. CMDs: 3-day theoretical training,
15 days practical training at health post.
- % CHWs and CMDs correctly performing
the step, observed over two years.
(1) Surface clean and flat - 87%
(2) Test opened just before use - 100%
(3) Document patient name and date - 83%
(4) Use of gloves - 0%
(5) 5 μL finger prick blood specimen - 93%
(6) 4 drops of solution buffer in right
well - 93%
(7) test rest on level surface - 97%
(8) waited maximum 15 minutes - 93%
Mubi [24] One week training. 99.7% of positive tests were correctly
interpreted throughout the 5-month
study period.
-
(I) Based on assessment of RDTs.
(II) Based on photographic assessment.
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[38], difficulties in transport [38], distance to health centre
[33,38] and lack of staff at the health centre which may re-
sult in long waiting hours [33].
Uptake of RDT based CCMm by members of the community
Three studies reported on the uptake by the community
of RDT-based CCMm in comparison to baseline levels
(pre-intervention period), presumptive CCMm or health
centre-based care (Table 5). Two studies showed an in-
creased use of RDT-based CCMm services over the study
period [15,27]. Additionally, one of the studies compared
it to health centre-based care and showed a constantnumber of visits in these clinics. It was concluded that
the overall access to malaria healthcare had thus in-
creased by the intervention [15]. These positive find-
ings are not always supported, as in a study of Lemma
et al. [40], the number of people visiting the randomly
selected CHWs who performed RDT-based CCMm
was half of those visiting CHWs who used presump-
tive diagnosis. The reasons for this reduction were not
further investigated. Obstacles for visiting the CHW
mentioned by the community in three other studies were
the unavailability of the CHW [16,37], dislike of CHW
services [37], distrust of the skills of the CHWs [37],
lack of drugs [37], fear of HIV/AIDs infection [35], a
Table 3 Adherence to test results by CHWs
Study Target population Treatment Alternative Adherence
overall*
Positives
treated
Negatives
treated
CCMm studies
Chanda [23,33] All ages, care seeking. AL, SP <5 kg Complicated malaria and non-malaria
febrile cases were referred to HF.
99.9% 99.3% 0.2%
Chinkhumba [30] >5 years, (history of) fever NS Referral not mentioned. 86.9% 98% 58%
Elmardi [27] NS AS/SP Complicated malaria and non-malaria
febrile cases were referred to HF.
70%** NS NS
Ishengoma [28] ≥5 years with (history of) fever AL Referral not specified. 95.8% 98.9% 5.4%
Mubi [24] >3 months, (history of) fever.
Exclusion: severe disease
AL Referral not specified. 96.8% 99.7% 6.1%
Ndiaye [20]*** Patients of all ages, care seeking. NS CHW: referral of patients <2 months,
RDT negatives, severe symptoms,
suspected drug adverse events. CMD:
referral of all cases excluding
uncomplicated malaria cases.
88.6% 92.0% 20.3%
Ndiaye [20]*** Patients of all ages, care seeking. NS CHW: Referral of patients <2 months,
RDT negatives, severe symptoms,
suspected drug adverse events.
85.6% 90.1% 24.8%
Ndiaye [20]*** Patients of all ages, care seeking. NS CMD: Referral of all cases excluding
uncomplicated malaria cases.
93.9% 95.3% 10.4%
iCCM studies
Hamer [17] &
Yeboah-Antwi [16]
Children 6 months-5 years, fever. AL Children with danger signs were
referred to HF.
99.3% 98.5% 0.4%
Mukanga [32] Children <5 (history of) fever
no danger signs.
AL CHWs also diagnosed and treated
pneumonia. No referral mentioned.
97.8% 98.6% 4.8%
Mukanga [34]**** BF: 6–59 months, (history of) fever AL Referral for severe disease and for
non-responders at day 3 after CHW visit.
99.0% 100% 4.8%
Mukanga [34]**** Gh: 6–59 months, (history of) fever AA Referral for severe disease and for
non-responders at day 3 after CHW visit.
99.5% 100% 3.3%
Mukanga [34]**** Ug: 4–59 months (history of) fever. AL Referral for severe disease and for
non-responders at day 3 after CHW visit.
99.0% 99.9% 7.6%
* = correct treatment, ** = percentage of CHWs that relied on RDT results, *** = adherence percentages calculated from study data, **** = CHWs attended review
meetings with study team each month discussing non-adherence to diagnostic and treatment algorithm with CHWs, HF = health facility, NS = not specified,
AL = artemether – lumefantrine, SP = sulphadoxine-pyrimethamine, AS = artesunate, ACT = artemisinin-based combination therapy (not further specified),
BF = Burkina Faso, Gh = Ghana, Ug = Uganda.
Table 4 Morbidity and mortality outcomes of RDT based CCMm strategies
Study Design Intervention Control Outcome
Mubi [24] RCT RDT-based CCMm Presumptive CCMm Increased perception of recovery in control group (97.3%)
versus intervention group (93.3%) at day 7. P = 0.000
Two malaria related deaths, one in each arm.
Thiam [25] NRCT RDT-based CCMm No CCMm Malaria related hospitalizations decreased by 43.1% in
intervention areas and 40.9% in control areas. Malaria
attributed deaths decreased by 62.5% in intervention
areas (significant decrease) and 23.4% in control areas
(no significant decrease).
Rutta [26] Pre-post study RDT-based CCMm
(with AL)
Comparison with pre-intervention
period (presumptive CCMm with SP)
A drop of >72.0% in malaria slide positivity rate to a
persistent low level of <10% was observed in the
study period.
Elmardi [27] Pre-post study RDT-based CCMm
(with AS/SP).
Comparison with pre-intervention
period (no CCMm, health centres
treated with AS/SP)
24% fever cases in last two weeks pre-intervention and
8.5% fever cases post intervention (p = 0.000).
61 deaths (all <5 years) in the last season
pre-implementation of intervention versus 1 death
(>5 years) in the season post-implementation (p = 0.000).
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Table 5 Healthcare-seeking behaviour
Study Intervention Control Outcome
Elmardi [27] RDT-based CCMm Comparison with pre-intervention
period (no CCMm)
Pre-intervention 25% of mothers of sick children <5 years would
seek care within the village, after the study 64.7% would seek care
within the village (p value).
Lemma [40] RDT-based CCMm Presumptive CCMm Only half the number of patients (5,123 patients) visited CHWs who
performed RDT-based CCMm compared with presumptive CCMm
(10,475 patients).
Tayler-Smith [15] RDT-based CCMm
free of charge
Health centre care, little payment
was required for ACT.
In two years there was an increase in number of episodes of treated
malaria per child per year from 0.4 to 1.2 for CHWs, whereas it
remained stable at 0.2 for health centres.
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handle [16], and the relative distance to the health
centre versus to the CHW [16,37].
Stock-outs
In the pre-intervention focus group discussions in the
study of Mukanga et al. [35], problems in lack of trans-
port for replenishment of supplies were foreseen. Four
studies mentioned stock-out problems [18,20,33,38].
The only other study that mentioned supply issues did
not experience any stock-out problems [27]. In all studies
the CHW was instructed to replenish stocks at an affiliated
health centre. Blanas et al. [38] found in 2009 that 74%
of villages did not have RDTs or the RDTs were expired.
In 68% of villages no ACT was available. However, Ndiaye
et al. [20] found in the same study area in 2010 and 2011,
that 90.2% of CHWs had RDTs in stock and 88% had suffi-
cient ACT in stock. It seems that experience over time
helped stock management, although in the latter study only
11.8% of all stock management forms were completed.
Stock-out problems were also found in the studies of
Chanda et al. [33] (stock-outs of RDTs for about two weeks)
and Counihan et al. [18] (stock-outs of drugs and RDTs).
One of the biggest problems for CHWs in the latter
study was the refusal of health centres to resupply the
CHWs. Health centres were either not informed about
the agreement on stock supply or they experienced
stock-outs themselves [18].
Motivation and remuneration of CHWs
Ndiaye et al. [20] showed that there was high seasonal
variation in CHW participation in Senegal. This could
be due to the difference in malaria burden but the au-
thors also suspect that the little remuneration and the
nearby gold mining activities had their impact on CHW
participation. CHWs are mostly considered volunteers, but
incentives such as small fees for their consultation [27],
compensation in material form or services [16,17,23,29], or
structured payments [17,24,26,30] were mentioned in most
studies. In Elmardi et al. [27] only 35% of CHWs were
satisfied with the financial outcome of their services
which was 0.5 US$ per consultation. However, when
these CHWs were asked about the most motivatingaspect of their work, it was not the financial compen-
sation but community respect and spiritual outcome.
This was supported by Hamer et al. [17] in which only
four of 18 CHWs received some kind of payment, but
almost all were satisfied or highly satisfied with their
CHW job (37 and 61%, respectively). There was no in-
formation on the impact of incentives and motivation
on the attrition of CHWs.Cost-effectiveness
Two studies on cost-effectiveness compared RDT-based
CCMm to presumptive CCMm [21,22] and a third
compared it with health centre- based malaria care [23]
(Table 6). All three studies did not have sufficient quality
for cost-effectiveness analyses as described in risk of bias
summary and all used a short-term outcome for health
benefit, that is cost per correctly treated case [22,23],
or related cost per case saved from unnecessary treatment
[21]. Compared to health centre-based care, costs for RDT-
based CCMm were lower per correctly treated case, but the
additional cost per change in case appropriately diag-
nosed and treated was 4.18 US$ for RDT-based CCMm
in Zambia [23]. RDT-based CCMm was also found to
cost less compared with presumptive CCMm for areas
with low to medium malaria transmission [22], but not in
high transmission areas as was shown in the Democratic
Republic of Congo [21]. Furthermore, study region could be
of importance as shown by Lemma et al. [22] in Ethiopia.
The study was situated in an area where Plasmodium vivax
is also prevalent and consequently the RDT that differenti-
ated between types of malaria species showed the lowest
costs per appropriately treated case. However, for total costs,
only differentiating between P. falciparum malaria and all
other fever cases was the cheapest option.Discussion
This review showed that CHWs are able to provide quali-
tative health care for malaria if properly trained. This is
substantiated by other reviews for shared outcomes [5-7].
Nevertheless some barriers are present for the success of
the intervention. The success and failure of each of the
steps in CCMm is discussed below.
Table 6 Cost-effectiveness of RDT based CCMm strategies
Study Intervention Control Malaria prevalence Outcome
Hawkes [21] RDT-based CCMm for
≥5-14 years, presumptive
<5 years old.
Presumptive treatment up to
14 years old.
88% by microscopy, for
calculations prevalence
of 80% was considered.
8.79 US$ for each case saved from unnecessary
treatment (total health budget per person per
year is 15$). Total costs three times as high for
RDT based CCMm.
Lemma [22] RDT-based CCMm for
P. falciparum with AL,
other febrile cases
treated with CQ.
Two comparisons. 1. RDT-based
CCMm for P. falciparum (AL)
and P. vivax (CQ) and referral
of all others.
Slide positivity rate 27.29%,
of which 70% P. falciparum.
Intervention: 4.66 US$ per correctly treated case.
Control 1. 1.69 US$ per correctly treated case.
Control 2. 11.08 US$ per correctly treated case.
2. Presumptive treatment
with AL for all fever patients.
Total costs were lowest for intervention strategy.
Chanda [23] RDT-based CCMm with
AL for all age groups
(free of charge)
Health centre-based care
(free of charge)
Prevalence 24% in RDT-based
CCMm and 26% in health
centres, either by RDT or
microscopy.
Cost per case appropriately diagnosed and
treated 4.22 US$ in RDT based CCMm
(mainly because of higher adherence) and
6.61 US$ in health centers. Additional cost
per change in case appropriately diagnosed
and treated was 4.18 US$.
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tivity and specificity of RDTs used by CHWs compared
with microscopy. A high sensitivity is needed because, as
the new first line of health care, RDT-based CCMm can-
not be inferior in detecting malaria cases to the existing
practices in health centres in which microscopy is often
used, especially because it seems that RDT negatives, in-
cluding false negatives, may not always reach a health
centre for additional care [33,39]. When the RDTs per-
formed by CHWs were compared to PCR the sensitivity
lowered but many of these cases were also missed by mi-
croscopy [29]. Furthermore, the clinical relevance of these
low parasitaemia cases is being debated, because they
are considered to be ubiquitous and usually asymptom-
atic, although it might cause anaemia [41]. Recent indi-
cations of a decreased malaria transmission in regions
in SSA could however lead to lower levels of immunity
in the population and might subsequently increase disease
susceptibility, also for subjects with low parasitaemia levels
[42]. RDT performance in case of low parasitaemia levels
will therefore become increasingly important, especially in
elimination settings.
Specificity levels were more variable, which is also seen
in RDT use by professional health-care workers [43]. This
is a potential threat to the success of CCMm as it could
lead to overtreatment and missed diagnoses of other fe-
brile illnesses. This could be a reason to promote the im-
plementation of iCCM, as other serious causes of fever,
such as pneumonia, will be detected with this interven-
tion. Factors influencing specificity could be microscopy
slide quality [24] and persistent circulating HRP2 antigens
(the diagnostic target of P. falciparum RDTs) after clear-
ance of the malaria infection [44]. The latter might explain
a lower specificity when a substantial part of individuals
received previous anti-malarial treatment [30] and the
lower specificity for individuals with a higher immunity
against malaria, such as children > five years of age inIshengoma et al. [28] and in Chinkhumba et al. [30]. An-
other possibility for a low specificity, though controversial,
could be that RDTs are more sensitive than micros-
copy, meaning that false positives were actually true
positives [43]. Support for this conclusion may be found
in Ratsimbasoa et al. who showed a higher specificity if
RDTs were compared with PCR than if RDTs were com-
pared with microscopy [29].
The performance of RDTs did not seem to be much
influenced by execution and interpretation of RDTs, as
these showed generally good results. It should however
be considered that all results were collected by (in)direct
evaluation of the CHWs and this may have biased the out-
come [45]. Job aid and training were factors positively asso-
ciated with interpretation and execution of RDTs, however,
this improvement could also be related to the selection bias
in CHWs. That would imply CHWs perform better with
higher educational background. Nevertheless progress
may still be obtained by increased practice of RDTs during
training [18,19], especially practice of interpretation of faint
positives and invalid test results and practice of the steps
that were found to be frequently problematic; these were
collecting blood in the right way and in the right amount,
dispensing buffer drops in the right amount and in the right
well, registering patient data and waiting the correct time
before reading test results [18-20]. It is unknown why these
steps were more problematic. Only one study reported an
event with high safety risk [18], but safety issues should
always be well addressed during training. Furthermore, vis-
ual impairments may hamper the correct interpretation of
RDTs [34] and therefore screening for visual impairments
should be done before appointing new CHWs.
RDT performance could also have been influenced
by 1) storage conditions [46], which stresses the need
of a cold chain, or 2) type of RDT, because of variable
intrinsic diagnostic qualities and differences in ease of
execution and interpretation. Many types of RDTs are
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review to advise on a specific type of test. Guidance for
RDT choice can be found in a published WHO report
which shows an extended overview of all different malaria
RDTs, although it should be noted that these were tested
in regulated circumstances by laboratory technicians, thus
not informing on end-user impact [47].
Adherence to test results and referral guidelines is im-
portant for safe and successful implementation of RDT-
based CCMm and the reviewed literature highlighted
that CHWs showed generally high levels of adherence to
test results regarding treatment. This in contrast to
professional healthcare workers, in whom adherence was
found to be much more variable because they often rely on
clinical judgment instead of RDT results [48-52] and the
fear of false-negative RDT results may tempt them to treat
negative patients, especially in the case of subjects with
no or little malaria immunity [53]. It could be that these
reasons also contributed to the few studies on CHWs
who reported non-adherence to negative test results
[20,27,30], especially because CHWs were previously
instructed to regard any fever case as malaria. This is
however unknown since CHW reasons for not adhering
to negative test results were not investigated, although
several studies stressed the importance of training and
monitoring in order for CHWs to adhere to the study
guidelines [17,18,23,24,26,28,30,32,33,40]. Interestingly, all
studies with an iCCM design showed good adherence to
negative RDT results. The provided alternatives for malaria
treatment in iCCM, such as antibiotic treatment for pneu-
monia after diagnosis with a respiratory rate timer, could
have contributed positively to this adherence.
Unfortunately, despite the importance of referring
patients with danger signs, adherence to referral policy
is scarcely addressed, with one study reporting low [20] and
one reporting high adherence [25]. Again, why CHWs
did not refer patients was not studied. From the patient
perspective, two studies investigated referral completion
and showed that many patients did not follow up on re-
ferral, although the big difference in magnitude between
these studies is remarkable [33,39]. Possible barriers for
patients to complete referral were found to be mostly
due to transportation difficulties; a problem that is even
bigger for health centre-based care and one that is not
easily solved, although iCCM could reduce the overall
need for referral. Other barriers were not thoroughly in-
vestigated; however an interesting finding was that RDT
result apparently influenced referral completion [39].
Studies on morbidity and mortality lacked high quality
evidence which impairs firm conclusions. CCMm should
be beneficial compared with presumptive CCMm by de-
creasing overtreatment, and increasing diagnoses of other
diseases. However, false negative RDT results could negate
the beneficial effects. The low evidence is surprising, butmay reflect the more challenging design needed, which
should incorporate follow-up of all patients.
The effect on morbidity and mortality in the total
population is dependent on acceptability and healthcare-
seeking behaviour of the community, which was found
to increase within the community after introduction of
RDT-based CCMm. It should, however, be noted that
the studies reporting on the uptake of CCMm with
RDTs took place during a trial, which could influence
the way people behave. This effect is better known as
the Hawthorne effect [45]. Several aspects were mentioned
as barriers of CCMm uptake in the reviewed studies. Even
though CHWs are mostly selected by the community or
community leaders and must often meet certain criteria of
educational background, barriers related to distrust of the
CHW are mentioned [37]. How often distrust is a problem
and what this is based upon is unknown. Better under-
standing of distrust might help in correctly sensitizing the
community to increase acceptance and uptake of CCMm.
Other barriers are logistical factors such as distance and
transport to CHW, unavailability of CHW and stock outs.
As CCMm already brings malaria care closer to the
patient’s home, problems of distance and transport are
not specific for community based healthcare and are
difficult to solve. Unavailability of the CHW might be
related to too little remuneration, limiting CHWs in
their time because they must take care of their liveli-
hood. CHW remuneration is shortly discussed below.
The issue of stock-outs seems to be a frequent problem
for RDTs and anti-malarial drugs [18,20,33,38]. Next to
the failure to provide patients the care they need at these
moments, even the rumour of stock-out could prevent
people from visiting CHWs [37]. The problem might be
even bigger after trial termination because stock supply
is usually more strictly regulated during study periods.
Experience with stock management by CHWs may have
a positive influence on the availability [20], but stock
management by CHWs is not always the main barrier
[33]. CHWs usually rely on nearby health facilities for
their stock supply but, due to financial, logistical, political,
and other factors, drug supply through the government
health systems is often unreliable and shortages of essen-
tial drugs are common in health centres as well, especially
in the most remote areas [54].
Another issue important for sustainability of RDT-based
CCMm is CHWs’ motivation and remuneration. It is
unfortunate that information is scarce and there is no
evaluation of motivation and the remuneration alterna-
tives on the subsequent retention of CHWs in RDT-
based CCMm. However, respect by the community and
spiritual outcomes seem to be important for motivation.
This was also reported in a recent Cochrane review that
informed on motivation for lay health workers involved
in all types of healthcare interventions [55]. Altruism,
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ment were mentioned as motivations. Discrepancies were
found in opinions on payment as incentive; supporters
thought their time investment and obtained skills should
be compensated, opponents thought working in a profit-
oriented way can evoke negative reactions within the com-
munity [56]. Non-monetary incentives, such as bicycles,
uniforms, mobile phones, or health insurance were gen-
erally well appreciated [56,57].
The last important item for long-term implementation,
in particular for policy makers, is cost-effectiveness. Cost-
effectiveness is highly dependent on malaria transmission,
infrastructure and existing health systems. It can be
concluded from the reviewed literature that the possible
monetary beneficial effects of RDT-based CCMm versus
presumptive CCMm are the biggest in areas with low to
moderate malaria prevalence, at least for the costs per
correctly treated case. With declining malaria prevalence
in many SSA countries, RDT-based CCMm will probably
become increasingly cost-effective [58]. However, because
of limitations in the study designs these cost-effectiveness
analyses are not informative enough for policy makers.
Most importantly not all health-related benefits were
included, such as the effect on longer term morbidity
and mortality. Also, the real-time information on malaria
prevalence that can be obtained with RDT testing is of
importance for malaria control programmes. Moreover,
testing with RDTs enables CHWs to adequately treat other
febrile diseases than malaria and is the first step in moving
from CCMm to iCCM. Because of these additional benefits,
cost-utility analyses on differences in disability or qual-
ity adjusted life years (DALYs or QALYs) would gain the
most information on the actual effects for patients and
the possible impact for society of RDT-based CCMm.
A number of limitations are present due to the scope
of this review. First of all, for several outcomes only a
few studies were found, limiting the amount of evidence.
Moreover, the few studies found were sometimes of insuffi-
cient quality for the relevant outcome, such as for morbid-
ity and mortality. In general, very few studies investigated
the factors that could explain why some of the critical
steps in CCMm are successful or not. Secondly, in con-
trast to outcomes of diagnostic quality, cost-effectiveness,
or impact of intervention on morbidity or mortality, it was
challenging to assess the risk of bias for the remaining
outcomes, because criteria for quality assessment were not
standardized. Thirdly, most outcomes were investigated
in trial settings, in which logistics are frequently well
arranged and motivation is high, but only until the end
of the study period. The lack of implementation studies
may therefore have caused a bias. Finally, the restric-
tion of the review to CCMm prevented the use of stud-
ies on iCCM without distinguishable CCMm data, but
this was the only way to establish the benefits andfailures of the individual intervention for the fight
against malaria. Nevertheless, integrated CCM is an
important development that may lead to increased ac-
cess to targeted healthcare, without jeopardizing but
potentially even improving malaria care.
Although the data presented in this review give a wealth
of information, several aspects warrant further studies.
First of all, no firm conclusions can be made on the abso-
lute impact of the test and treat policies on morbidity and
mortality. Further studies appropriately designed to meas-
ure this effect are needed and should preferably include
follow-up of all patients, including referred and RDT-
negative patients to also estimate the change in detection
of other febrile diseases. Proven effect on morbidity and
mortality will help policy makers in their decision about
implementation of the intervention.
Furthermore, this review has shown that social science
contributions are scarce. This limits the understanding of
the implementation of RDT-based CCMm in different
local contexts. Multidisciplinary approaches in which bio-
medical and social sciences asses the intervention, both by
qualitative and quantitative methods, are needed. Factors
influencing adherence to test results, referral completion,
acceptance and uptake of the intervention and CHW attri-
tion need to be more thoroughly investigated. Moreover,
research is required to assess the best and most sustain-
able way of (re)training and supervising CHWs.
Little is published on logistic and structural elements,
which would allow the design of a sustainable programme.
Therefore, the system of stock supply and stock manage-
ment throughout the healthcare system should be outlined
and analysed to detect the problem areas.
Conclusions
Despite limitations of the currently available evidence, sev-
eral recommendations can be made for the design and im-
plementation of CCMm. It is most important that CHWs
receive a training in which they have enough opportunity
to practice the difficult steps and interpretation of RDTs
to ensure adequate execution and interpretation of the
tests and consequently ensure the most optimal test per-
formance. Furthermore, the risks derived from potentially
lower specificity may be outweighed if iCCM is imple-
mented. A job aid, repeated training and supervision can
subsequently enhance the overall performance of CHWs,
including adherence to test results. Again, further im-
provement in adherence can be obtained by implementing
iCCM. Community sensitization is needed to ensure com-
prehension of the intervention and trust in the skills of the
CHW. Furthermore, it might stimulate adherence to treat-
ment and referral advice. The stock management system
needs to be elucidated and stock management training
should be an integrated part in the CHW and health
centre staff training.
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abundant and variable in different malaria-endemic areas
and because the scarce number of studies available lack
the inclusion of important benefits, an individual cost-
effectiveness analysis is still needed for each area prepar-
ing for RDT-based CCMm implementation [58].
The implications raised in this review can be used to
draft RDT-based CCMm or iCCM programmes and re-
search projects, even for risk groups not explicitly ad-
dressed in most RDT-based CCMm studies, such as
pregnant women. However, specific considerations
would be in place depending on malaria pathogenesis,
transmission dynamics, the existing healthcare struc-
ture and the local culture and social setting.
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